Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

FP6 CLINICIP logo

CLINICIP

Project ID: 506965
Finanziato nell'ambito di

Closed Loop INsulin Infusion for Critically Ill Patients

Dal 2004-01-01 al 2007-12-31, progetto concluso | CLINICIP Sito web

Dettagli del progetto

Costo totale:

EUR 11 256 588,46

Contributo UE:

EUR 7 500 000

Coordinato in:

Austria

Invito a presentare proposte:

FP6-2002-IST-1See other projects for this call

Meccanismo di finanziamento:

IP - Integrated Project

Description

Intelligent glucose monitoring

Devices to regulate the blood-sugar levels of critically ill patients in intensive care wards are set to improve treatment and even save lives when they go into commercial use in the coming years.

Developed by the CLINICIP project, the intelligent devices address a potentially fatal side effect of trauma and shock: rapid increases in the body’s glucose levels that intensive care unit (ICU) doctors and nurses have typically found hard to control.

As with diabetes, high glucose levels in trauma patients can be brought down through infusions of insulin. However, in an ICU environment the changes are often more rapid, and an excessive dose of insulin can lead to dangerously low blood sugar, a condition known as hypoglycaemia.

Controlling the risks of irregular blood sugar

The CLINICIP team saw where technology could come to the aid of ICU patients. Working in collaboration with several European hospitals, they developed and tested a device to support nurses in deciding how much insulin and how frequently to administer it, while also working towards a more advanced system that would automate insulin injections entirely.

The decision-support device, which is expected to be commercially available in 2009 after further trials, still relies on nurses drawing blood from patients and testing glucose levels in the traditional way.

However, instead of administering the insulin directly they input the glucose information into the device via a touch screen. A specially designed algorithm then calculates how much insulin is needed before administering it to the patient. The device alerts nurses when blood samples need to be taken, which can be as frequently as every half hour.

Using the system in trials, just one hypoglycaemic event was recorded in 434 ICU days.

Automatic insulin injections

The automated version of the system, which the project partners expect to make available commercially in 2011, goes one step further in order to minimise the need for nurses to intervene.

Using a glucose-monitoring interface and an insulin-infusion interface in a closed-loop system, the device draws blood samples from the patient automatically, calculates the insulin required to bring their blood sugar within normal levels, then administers the correct dose.

Improving patients’ chances of survival

Clinical trials in Europe have shown that such a device would probably dramatically improve the survival chances of critically ill patients who develop irregular glucose levels. Although hospitals frequently check blood sugar in ICU patients, few have implemented tight controls because of the risks of overcompensating and the need to have more nursing staff dedicated to glucose control.

CLINICIP’s automated system overcomes both those problems, while its decision-support device reduces the risks of nurses giving an incorrect insulin dose.

Obiettivo

Healthy people can develop atypical physiological symptoms under critically ill conditions, e.g. in the intensive care unit (ICU). Due to shock and trauma as a consequence of the surgery, the glucose concentration is likely to rise significantly comparable to the symptoms known as insulin-dependent Diabetes Mellitus. Similar to diabetes mellitus, the high glucose level needs to be treated with external insulin. According to a study in Belgium the intensive insulin therapy treatment cuts the mortality rates by 42% compared to standard insulin therapy for ICU indication.The project provides an intelligent system for improved health status monitoring of critically ill patients. A local system will be developed comprising biosensors for the determination of glucose in whole blood. Based on the continuous measurement, an adaptive control algorithm generates advice and thus represents a decision supporting system in an early project stage. Within a closed loop system intensified insulin treatment will make use of calculation results leading to the external regulation of glucose. In addition to the approach of controlling the glucose concentration, a minimally invasive treatment will be investigated. A number of biosensors for the determination of most important parameters such as lactate, carbon dioxide, oxygen and pH will be used to characterize adipose tissue.In order to support the implementation of intensified treatment in an optimal way, a telemedical infrastructure will be developed. This includes a knowledge sharing environment, allowing the involved clinical centres to store and share their newly generated knowledge. Additionally all data resulting from clinical trials will be saved on the server. In later stages of the project, access to the data and the derived clinical recommendations for treatment of critically ill patient will be granted to additional clinical partners who are willing to implement improved treatment.

Informazioni correlate

Documenti e pubblicazioni

Multimedia

Contatto coordinatore

Karin Rehatschek, (Project Coordinator)
Tel.: +43-316-8761144
Fax: +43-316-8761191
E-mail

Coordinatore

JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
Austria

Contributo UE: EUR 1 907 976


LEONHARDSTRASSE 59
8010 GRAZ
Austria
Activity type: Research Organisations
Contatto amministrativo: Karin Rehatschek
Tel.: +433168761144
Fax: +433168761191
E-mail

Partecipanti

TECHNISCHE UNIVERSITAET GRAZ
Austria

Contributo UE: EUR 421 905


RECHBAUERSTRASSE 12
8010 GRAZ
Austria
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Ingo Klimant
Tel.: 00433168734328
Fax: 00433168738304
E-mail
UNIVERSITAET GRAZ
Partecipazione terminata
Austria

Contributo UE: EUR 0


Universitaetsplatz 3
8010 GRAZ
Austria
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Martin Ellmerer
Tel.: +433168762145
Fax: +433168762130
E-mail
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

Contributo UE: EUR 583 449


Oude Markt 13
3000 LEUVEN
Belgium
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Greet Van den Berghe
Tel.: +32 16 344013
Fax: +32 16 344015
E-mail
UNDEFINED
Partecipazione terminata
Belgium

Contributo UE: EUR 0


Street, 1
Town
Belgium
Activity type: Other
Contatto amministrativo: Firstname2 Lastname2
Tel.: 0123456789
Fax: 0123456789
UNIVERZITA KARLOVA V PRAZE
Czech Republic

Contributo UE: EUR 687 425


Ovocny trh 5
11636 PRAHA 1
Czech Republic
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Martin Haluzik
Tel.: +420224962908
Fax: +420224919780
E-mail
GAMBRO DIALYSATOREN GMBH
Germany

Contributo UE: EUR 385 802


HOLGER-CRAFOORD-STRASSE 26
72373 HECHINGEN
Germany
Activity type: Other
Contatto amministrativo: Bernd Krause
Tel.: +497471171218
Fax: +497471171152
E-mail
LEIBNIZ-INSTITUT FUR ANALYTISCHE WISSENSCHAFTEN-ISAS-EV
Germany

Contributo UE: EUR 528 017,40


BUNSEN KIRCHHOFF STRASSE 11
44139 DORTMUND
Germany
Activity type: Research Organisations
Contatto amministrativo: Herbert Michael Heise
Tel.: +492311392215
Fax: +492311392120
E-mail
SENSLAB GESELLSCHAFT ZUR ENTWICKLUNG UND HERSTELLUNG BIOELEKTROCHEMISCHER SENSOREN MBH
Germany

Contributo UE: EUR 404 667


BAUTZNER STR. 67
04347 LEIPZIG
Germany
Activity type: Other
Contatto amministrativo: Heiko Wedig
Tel.: +493412341850
Fax: +493412341840
E-mail
B. BRAUN MELSUNGEN AG
Germany

Contributo UE: EUR 283 785


CARL BRAUN STRASSE 1
34212 MELSUNGEN
Germany
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Hans-Martin Lauer
Tel.: +4989839409 50
Fax: +4989839409 55
E-mail
CONSIGLIO NAZIONALE DELLE RICERCHE
Italy

Contributo UE: EUR 361 530


PIAZZALE ALDO MORO 7
00185 ROMA
Italy
Activity type: Research Organisations
Contatto amministrativo: Francesco Baldini
Tel.: +390554235258
Fax: +390554235356
E-mail
CARMEDA AB
Partecipazione terminata
Sweden

Contributo UE: EUR 12 000


KANALVAGEN 3B
194 61 UPPLANDS VASBY
Sweden
Activity type: Other
Contatto amministrativo: Erik Holmer
Tel.: +46850551225
Fax: +46850551299
E-mail
The Chancellor, Masters and Scholars of the University of Cambridge
United Kingdom

Contributo UE: EUR 543 600


Madingley Road
CB3 0TX Cambridge
United Kingdom
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Roman Hovorka
Tel.: +441223762862
Fax: +441223336996
E-mail